Trial site
Tangdu Hospital
Xi'an, Shaanxi 710038, ChinaNot linked to an institution yet
- 17running trials
- 11closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Phase
- Phase 37 trials
- Phase 1/23 trials
- Phase 23 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting14 trials
- Completed10 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Tang-Du Hospital16 trials
- Xijing Hospital4 trials
- Janssen Research & Development, LLC2 trials
- Denovo Biopharma LLC1 trial
- Hoffmann-La Roche1 trial
- and 4 more
Running trials
Not yet recruiting
A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UC
NCT07705126· Tang-Du Hospital· Source
Contact: Xin Wang
Recruiting
Intra-arterial Methylprednisolone After Endovascular Thrombectomy
NCT07516522· Phase 2· Tang-Du Hospital· Source
Contact: Wei Guo, MD
Recruiting
Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)
NCT07354061· Phase 1/2· Tang-Du Hospital· Source
Contact: Zhang
Recruiting
Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT07377305· Tang-Du Hospital· Source
Contact: Jun GUO, Dr
Recruiting
Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
NCT07141303· Phase 3· Tang-Du Hospital· Source
Contact: Wei Guo, MD
Recruiting
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma
NCT06979869· Xijing Hospital· Source
Contact: Xianchun Gao, doctor
Recruiting
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer
NCT06979895· Xijing Hospital· Source
Contact: Xianchun Gao, doctor
Recruiting
Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
NCT06864624· Phase 2· Tang-Du Hospital· Source
Contact: Shicao Li
Recruiting
A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
NCT06447597· Phase 2/3· Shanghai Jiaolian Drug Research and Development Co., Ltd· Source
Contact: Ting Chang
Recruiting
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
NCT06467786· Phase 4· Tang-Du Hospital· Source
Contact: Haichuan Su, PhD
Recruiting
Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
NCT06231264· Xijing Hospital· Source
Contact: Ning Wang
Active, not recruiting
Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB Resectable NSCLC (FORESEE)
NCT05430802· Phase 2· Tang-Du Hospital· Source
Recruiting
Ofatumumab in AQP4-IgG Seropositive NMOSD
NCT05504694· Phase 1/2· Tang-Du Hospital· Source
Contact: Jun Guo, M.D.
Recruiting
Assessment of Brain Cognitive Impairment in Breast Cancer
NCT05305092· Tang-Du Hospital· Source
Contact: Menghui Yuan, PHD
Recruiting
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
NCT05032053· Xijing Hospital· Source
Contact: Wei Zhang
Recruiting
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
NCT03093116· Phase 1/2· Turning Point Therapeutics, Inc.· Source
Contact: Haichuan Su, Site 6754
Recruiting
The Early Warning System for the Diabetic Encephalopathy
NCT02420470· Tang-Du Hospital· Source
Contact: Ying Yu, master
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
3D-Printed Artificial Airway Fixation Device for Obese Patients
NCT07349433· Tang-Du Hospital· Source
Completed
Optimizing Early Nutrition Support in Severe Stroke-2
NCT05998902· Phase 3· Wen Jiang-3· Source
Completed
Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
NCT06196723· Tang-Du Hospital· Source
Completed
Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension
NCT06245798· Tang-Du Hospital· Source
Completed
Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function
NCT06245785· Tang-Du Hospital· Source
Completed
Development and Validation of a Deep Learning-Based Survival Prediction Model for Pediatric Glioma Patients: A Retrospective Study Using the SEER Database and Chinese Data
NCT06199388· Tang-Du Hospital· Source
Terminated
A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis
NCT04963270· Phase 3· Hoffmann-La Roche· Source
Completed
A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
NCT03776071· Phase 3· Denovo Biopharma LLC· Source
Completed
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
NCT04846491· Phase 3· Xiamen Amoytop Biotech Co., Ltd.· Source
Completed
A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma
NCT03234972· Phase 3· Janssen Research & Development, LLC· Source
Completed
A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)
NCT03217812· Phase 3· Janssen Research & Development, LLC· Source
Report an error